Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
chendol tablets 250 milligram
cp pharmaceuticals ltd trading as wockhardt uk - chenodeoxycholic acid - tablets - 250 milligram
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
chenofalk capsule 250 milligram
mercury pharmaceuticals (ireland) ltd - chenodeoxycholic acid - capsule - 250 milligram
Singapur -
angielski -
HSA (Health Sciences Authority)
sandostatin lar for injection 10 mg
novartis (singapore) pte ltd - octreotide acetate 11.2mg eqv octreotide - injection - 10 mg/vial - octreotide acetate 11.2mg eqv octreotide 10 mg/vial
Singapur -
angielski -
HSA (Health Sciences Authority)
sandostatin lar for injection 20 mg
novartis (singapore) pte ltd - octreotide acetate 22.4mg eqv octreotide - injection - 20 mg/vial - octreotide acetate 22.4mg eqv octreotide 20 mg/vial
Singapur -
angielski -
HSA (Health Sciences Authority)
sandostatin lar for injection 30 mg
novartis (singapore) pte ltd - octreotide acetate 33.6mg eqv octreotide - injection - 30 mg/vial - octreotide acetate 33.6mg eqv octreotide 30 mg/vial
Singapur -
angielski -
HSA (Health Sciences Authority)
sandostatin injection 0.1 mgml
novartis (singapore) pte ltd - octreotide - injection - 0.1 mg/ml - octreotide 0.1 mg/ml
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
renacet 475mg tablets
stanningley pharma ltd - calcium acetate - oral tablet - 475mg
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
renacet 950mg tablets
stanningley pharma ltd - calcium acetate - oral tablet - 950mg
Nowa Zelandia -
angielski -
Medsafe (Medicines Safety Authority)
sandostatin
novartis new zealand ltd - octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base - solution for injection - 0.05 mg/ml - active: octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base excipient: lactic acid mannitol sodium bicarbonate water for injection
Nowa Zelandia -
angielski -
Medsafe (Medicines Safety Authority)
sandostatin
novartis new zealand ltd - octreotide acetate 0.112 mg/ml equivalent to 0.1 mg/ml octreotide base - solution for injection - 0.1 mg/ml - active: octreotide acetate 0.112 mg/ml equivalent to 0.1 mg/ml octreotide base excipient: lactic acid mannitol sodium bicarbonate water for injection